Your session is about to expire
← Back to Search
Remibrutinib for Peanut Allergy
Study Summary
This trialtests if a drug can help people with peanut allergies tolerate higher doses of peanut protein.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- There may be additional requirements or restrictions for participating in the study that are specific to the study protocol.You have had a very serious allergic reaction that required you to be admitted to the intensive care unit or be put on a breathing machine within the past two months.My asthma is not well-managed with current treatments.I am taking blood thinners, but aspirin or clopidogrel might be okay.I have a bleeding risk or a disorder that affects my blood's ability to clot.I do not have any major health issues that could make the trial unsafe for me.I have had my spleen removed.You have a history of being allergic to peanuts.
- Group 1: remibrutinib low dose
- Group 2: remibrutinib medium dose
- Group 3: remibrutinib high dose
- Group 4: placebo 3 week / remibrutinib low dose 1 week
- Group 5: placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are any of the test subjects in this clinical trial over 20 years old?
"The age bracket for this particular clinical trial is 18 to 55. In total, there are 86 clinical trials involving patients that are minors and 162 concerning senior citizens."
How does remibrutinib high dose compare to other treatments in terms of safety?
"Remibrutinib high dose falls at a 2 on our 1-3 scale because, although there is some evidence suggesting it is safe, there is no data affirming that the medication is effective."
Is this research effort actively looking for participants at the moment?
"Yes, the most recent information on clinicaltrials.gov indicates that this trial is still recruiting patients. This particular study was posted on October 12th, 2020 and edited November 2nd, 2020. The goal is to have 110 enrollees at 1 location."
Who does this clinical trial seek as participants?
"The requirements to take part in this experiment are having a peanut allergy and being between 18-55 years old. So far, 110 individuals have signed up."
Share this study with friends
Copy Link
Messenger